21ˢᵗ Century Trials in New-Onset T1D
How the Use of C-Peptide can Accelerate the Development of Next-Gen Disease-Modifying Therapies for T1D
Until the Event starts
By submitting you agree to the Terms & Privacy Policy
A Workshop to Define the Path Forward
The purpose of this scientific workshop is to gather researchers, physicians, industry, patient advocacy and regulators in order to discuss the current evidence for the use of c-peptide as an endpoint in clinical trials of new-onset T1D. We aim to reach conclusions and achieve clarity on next steps.
Why Attend the Virtual Workshop
This important discussion will:
• Discuss the context of use for c-peptide in clinical trials
• Catalyze decision making for disease modifying therapies
• Clarify regulatory stance on c-peptide as an endpoint
• Decide next steps for the T1D drug development community
Say Hello To Our Speakers
We couldn't be more excited about our lineup. Which talks will you be checking out?
Schedule
Take a look at the exciting agenda we have planned for you.